Cargando…
COVID-19 and the liver: Are footprints still there?
The coronavirus disease 2019 (COVID-19) hit the entire world as a global pandemic and soon became the most important concern for all patients with chronic diseases. An early trend in higher mortality in patients with acute respiratory distress attracted all researchers to closely monitor patients fo...
Autores principales: | Gupta, Tarana, Sharma, Hemant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896610/ https://www.ncbi.nlm.nih.gov/pubmed/36742164 http://dx.doi.org/10.3748/wjg.v29.i4.656 |
Ejemplares similares
-
Ribosomal footprints on a transcriptome landscape
por: Morris, David R
Publicado: (2009) -
Of mice and men: phylogenetic footprinting aids the discovery of regulatory elements
por: Zhang, Zhaolei, et al.
Publicado: (2003) -
Clinical and pathophysiological understanding of the hepatorenal syndrome: Still wrong or still not exactly right?
por: Wilde, Benjamin, et al.
Publicado: (2023) -
Still 'dwelling in the possibility' - critical update on stem cell therapy for acute on chronic liver failure
por: Philips, Cyriac Abby, et al.
Publicado: (2020) -
COVID-19 in liver transplant patients: Impact and considerations
por: Khazaaleh, Shrouq, et al.
Publicado: (2023)